A study of factors that may influence the neurocognitive health of HIV+ populations: For better- early antiretroviral therapy? For worse- cardiovascular risk factors and disease?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1016820

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cognitive health is of primary importance to HIV affected communities. Recently high blood pressure and high cholesterol have been associated with poor cognitive performance in middle aged HIV+ patients. We plan to study whether HIV+ patients with cardiovascular risk factors have faster and more frequent cognitive decline than HIV+ and HIV- patients without these risk factors. In another study we plan to determine the potential benefits of early versus deferred HIV antiretroviral therapy upon neurocognitive performance.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Early Career Fellowships

Funding Amount: $362,123.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular risk factors | cognitive assessment | cognitive impairment | controlled trial | dementia | early prevention | human immunodeficiency virus (HIV) | prospective cohort study

Related Links